AI discovers anti-aging drugs: Combination could stave off declines in eye sight, Alzheimer's

Artificial intelligence technology helped researchers identify a trio of chemicals that target faulty cells linked to age-related health issues, including certain cancers and Alzheimer's disease. The algorithm comb through a library of more than 4,300 chemical compounds and identified 21 drug candidates that could prompt cell senescence. This is a phenomenon in which faulty cells stop multiplying but do not die off as they should and continue to release chemicals that can trigger inflammation. Of those 21 candidates, the scientists zeroed in on three compounds – ginkgetin, oleandrin, and periplocin – which were able to remove defective cells without harming healthy ones when tested on human cells. AI is increasingly becoming a fixture in medical and scientific research, able to sift through mountains of dense data far faster than a human ever could to aid in the diagnosis of and treatment for diseases.